The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium.

scientific article published in June 2001

The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11406562

P2093author name stringGlinsky GV
Deutscher SL
Quinn TP
Huflejt ME
Rittenhouse-Olson K
Glinsky VV
Glinskii OV
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectendotheliumQ111140
prostate cancerQ181257
P304page(s)4851-4857
P577publication date2001-06-01
P1433published inCancer ResearchQ326097
P1476titleThe role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium
P478volume61

Reverse relations

cites work (P2860)
Q35066670A marine analgesic peptide, Contulakin-G, and neurotensin are distinct agonists for neurotensin receptors: uncovering structural determinants of desensitization properties
Q37328722A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction
Q37302910ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis
Q36950893Aberrant glycosylation of the anti-Thomsen-Friedenreich glycotope immunoglobulin G in gastric cancer patients
Q35201294Aberrant glycosylation promotes lung cancer metastasis through adhesion to galectins in the metastatic niche
Q46678523Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium
Q37581540Altered tumor-cell glycosylation promotes metastasis
Q84075613Analysis of the neutral polysaccharide fraction of MCP and its inhibitory activity on galectin-3
Q40279445Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging
Q24658379Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier
Q38314353Binding of galectin-1 (gal-1) to the Thomsen-Friedenreich (TF) antigen on trophoblast cells and inhibition of proliferation of trophoblast tumor cells in vitro by gal-1 or an anti-TF antibody
Q36298206Bioconjugation and detection of lactosamine moiety using alpha1,3-galactosyltransferase mutants that transfer C2-modified galactose with a chemical handle
Q35993085CD176 single-chain variable antibody fragment inhibits the adhesion of cancer cells to endothelial cells and hepatocytes
Q35525289Cancer vaccines and carbohydrate epitopes
Q47134233Cell surface Thomsen-Friedenreich proteome profiling of metastatic prostate cancer cells reveals potential link with cancer stem cell-like phenotype
Q28255527Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface
Q24597542Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis
Q31142810Combinatorial evolution of high-affinity peptides that bind to the Thomsen-Friedenreich carcinoma antigen
Q40292897Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasis
Q60367969Continuous real time ex vivo epifluorescent video microscopy for the study of metastatic cancer cell interactions with microvascular endothelium
Q61903522Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity
Q36200540Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines
Q33489506Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen
Q92812834Does Direct and Indirect Exposure to Ionising Radiation Influence the Metastatic Potential of Breast Cancer Cells
Q31047849Effective combinatorial strategy to increase affinity of carbohydrate binding by peptides
Q33576873Endothelial integrin α3β1 stabilizes carbohydrate-mediated tumor/endothelial cell adhesion and induces macromolecular signaling complex formation at the endothelial cell membrane
Q90397869Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate
Q35892475Epithelial-to-Mesenchymal Transition of RPE Cells In Vitro Confers Increased β1,6-N-Glycosylation and Increased Susceptibility to Galectin-3 Binding
Q40606989Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells
Q28255822Expression of MUC1 and CD176 (Thomsen-Friedenreich antigen) in papillary thyroid carcinomas
Q34522377Expression of antigen tf and galectin-3 in fibroadenoma
Q38225141Extracellular galectin-3 in tumor progression and metastasis.
Q42012840Extravasation of leukocytes in comparison to tumor cells.
Q33935217Far beyond the usual biomarkers in breast cancer: a review
Q36741513Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens
Q35646658Galectin-3 and metastasis
Q36326176Galectin-3 as a Potential Target to Prevent Cancer Metastasis.
Q35945071Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia.
Q34626339Galectin-3: a potential target for cancer prevention.
Q38160862Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers
Q42288169Glycoamino Acid Analogues of the Thomsen-Friedenreich Tumor-Associated Carbohydrate Antigen: Synthesis and Evaluation of Novel Antiproliferative Factor Glycopeptides
Q27008374Glycoconjugates and related molecules in human vascular endothelial cells
Q92724165Glycosylation in the Tumor Microenvironment: Implications for Tumor Angiogenesis and Metastasis
Q38757500Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability
Q41478234Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis
Q93186392Immunological Regulation of Vascular Inflammation During Cancer Metastasis
Q36339643Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer
Q34208137Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential
Q34360666Inhibition of metastatic tumor formation in vivo by a bacteriophage display-derived galectin-3 targeting peptide
Q35763903Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine.
Q35249810Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11
Q39690197Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis.
Q26749378Interaction of the Oncofetal Thomsen-Friedenreich Antigen with Galectins in Cancer Progression and Metastasis
Q35646606Introduction to galectins
Q38024987Isolated, disseminated and circulating tumour cells in prostate cancer
Q36002985MUC1 is involved in trophoblast transendothelial migration
Q34768486Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs
Q24651188Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
Q98465934Molecular mechanisms and clinical management of cancer bone metastasis
Q34536725Mucin-interacting proteins: from function to therapeutics
Q24561606NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin
Q34500864Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer.
Q36776494Onco-Golgi: Is Fragmentation a Gate to Cancer Progression?
Q27014902Organelle targeting: third level of drug targeting
Q49901112Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1.
Q33532734Phage display in molecular imaging and diagnosis of cancer
Q38359737Poly N-acetyllactosamine substitutions on N- and not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3.
Q37316672Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients
Q52686871Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging.
Q91844287Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
Q33770947Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis
Q43164816Regulation of tumor progression by extracellular galectin-3.
Q35160084Sialyltransferases in cancer
Q38366325Simple sugars to complex disease--mucin-type O-glycans in cancer
Q36956344Stepping out of the flow: capillary extravasation in cancer metastasis
Q35162645Synthesis and cell-selective antitumor properties of amino acid conjugated tumor-associated carbohydrate antigen-coated gold nanoparticles
Q37642032Synthesis of the tumor associative α-aminooxy disaccharide of the TF antigen and its conjugation to a polysaccharide immune stimulant.
Q37328110Synthetic galectin-3 inhibitor increases metastatic cancer cell sensitivity to taxol-induced apoptosis in vitro and in vivo.
Q98771478Targeting Galectins With Glycomimetics
Q58712952Temporal and molecular dynamics of human metastatic breast carcinoma cell adhesive interactions with human bone marrow endothelium analyzed by single-cell force spectroscopy
Q37333778The inhibitory effects of a rhamnogalacturonan I (RG-I) domain from ginseng pectin on galectin-3 and its structure-activity relationship
Q34622638The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression
Q21093318The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis
Q28261890The roles of Galectin-3 in autoimmunity and tumor progression
Q26744538Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer
Q36853557Varied presentation of the Thomsen-Friedenreich disaccharide tumor-associated carbohydrate antigen on gold nanoparticles

Search more.